We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

65 hedge funds and large institutions have $72.7M invested in OptiNose in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 20

0.23% less ownership

Funds ownership: 5.05%4.81% (-0.23%)

23% less funds holding

Funds holding: 8465 (-19)

36% less capital invested

Capital invested by funds: $114M → $72.7M (-$41.7M)

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

83% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 23

Holders
65
Holders Change
-19
Holders Change %
-22.62%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.01%
New
4
Increased
20
Reduced
20
Closed
23
Calls
Puts
Net Calls
Net Calls Change

OPTN Hedge Fund Activity: Q3 2024 in Review

65 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q3 2024, worth a combined $72.7M — down 36% from $114M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of OPTN and 4 opened new positions — a net loss of 19 holders — while 20 trimmed existing stakes and 20 added.

The largest buyer was Stonepine Capital Management, adding an estimated $3.25M. The largest seller was BlackRock, cutting an estimated $4.37M.

  • 65 institutional investors held OptiNose (OPTN) as of Q3 2024, down from 84 in Q2 2024.
  • Funds reported $72.7M of OptiNose stock for Q3 2024, down 36% quarter-over-quarter.
  • 4 funds opened new OptiNose positions in Q3 2024 and 23 closed out, a net change of -19 holders.
  • The largest OptiNose buyer in Q3 2024 was Stonepine Capital Management, an estimated $3.25M added.
  • The largest OptiNose seller in Q3 2024 was BlackRock, an estimated $4.37M sold.

Based on aggregated 13F filings for Q3 2024.